back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-06-16 17:06 Tx date 2025-06-12 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,000
+500,000 vol $0.05 each |
2,700,000 | |
| Filed 2025-03-19 13:48 Tx date 2025-03-17 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$48,998
+699,980 vol $0.07 each |
3,200,030 | |
| Filed 2025-03-19 13:46 Tx date 2024-06-12 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$46,528
+299,993 vol $0.1551 each |
2,000,050 | |
| Filed 2025-03-19 13:45 Tx date 2024-06-11 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$75,100
+500,000 vol $0.1502 each |
1,700,057 | |
| Filed 2025-03-19 13:44 Tx date 2024-06-10 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,941
+200,007 vol $0.1497 each |
1,200,057 | |
| Filed 2025-02-24 16:39 Tx date 2025-02-21 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,000
+200,000 vol $0.12 each |
2,200,000 | |
| Filed 2024-11-12 10:53 Tx date 2024-11-11 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$35,065
+289,800 vol $0.121 each |
1,500,050 | |
| Filed 2024-11-12 10:52 Tx date 2024-11-11 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,224
+210,200 vol $0.12 each |
1,210,250 | |
| Filed 2023-11-14 16:42 Tx date 2023-11-07 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$400,000
+2,000,000 vol $0.20 each |
2,000,000 | |
| Filed 2023-11-09 16:13 Tx date 2023-11-07 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$380,000
+2,000,000 vol $0.19 each |
||
| Filed 2023-11-09 16:13 Tx date 2023-11-07 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$380,000
+2,000,000 vol $0.19 each |
2,000,000 | |
| Filed 2023-11-09 16:12 Tx date 2023-11-06 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-11-09 16:11 Tx date 2023-11-06 |
$ZOM
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,000,050 |